Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tina R. Herold"'
Autor:
Benedikt Schworm, Nikolaus Luft, Leonie F. Keidel, Thomas C. Kreutzer, Tina R. Herold, Siegfried G. Priglinger, Jakob Siedlecki
Publikováno v:
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background To investigate the diagnostic value of choroidal thickness in the definition of pachychoroid neovasculopathy (PNV), especially in eyes treated with anti-vascular endothelial growth factor (VEGF) therapy. Methods Twenty-two consecu
Externí odkaz:
https://doaj.org/article/f56de0181b154234864b577fe4603cbe
Autor:
Tina R, Herold, Efstathios, Vounotrypidis, Raffael, Liegl, Susanna F, Koenig, Siegfried G, Priglinger, Armin, Wolf
Publikováno v:
Retina. 42:1392-1398
The aim of our prospective off-label, interventional clinical trial was to evaluate the efficacy and safety of the fluocinolone-loop-anchoring technique over two years in eyes with iris-lens diaphragm disruption and pseudophakic cystoid macular edema
Autor:
Denise Vogt, Viktoria Deiters, Tina R. Herold, Stefanie R. Guenther, Karsten U. Kortuem, Siegfried G. Priglinger, Armin Wolf, Ricarda G. Schumann
Publikováno v:
Current eye research. 47(6)
To report on long-term real-life outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy in neovascular age-related macular degeneration (nAMD) with optimal patient adherence.For this retrospective monocenter study, we identified 3217
Autor:
Ricarda G, Schumann, Tina R, Herold, Christos, Haritoglou, Ma Thi As M, Maier, Albrecht, Lommatzsch
Publikováno v:
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen GesellschaftLiteratur. 118(3)
Advances in imaging techniques of the retina have substantially enhanced our current understanding of the pathogenesis, morphology and prognosis of vitreomacular retinal diseases. Optical coherence tomography-based criteria and classification systems